Affiliations 

  • 1 Department of Oncology, Oral Medicine and Oral Oncology Unit, University of Turin, Turin, Italy
  • 2 Department of Stomatology, Division of Oral Medicine, Medical University of South Carolina, Charleston, Charleston, SC, USA
  • 3 Department of Oral Medicine and Periodontology, Faculty of Dental Sciences, University of Peradeniya, Peradeniya, Sri Lanka
  • 4 Head and Neck Cancer Research Team, Cancer Research Malaysia, Subang Jaya,, Selangor, Malaysia
  • 5 Australian Centre for Oral Oncology Research & Education, UWA Dental School, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia
  • 6 New York University College of Dentistry, New York, NY, USA
  • 7 Sjogren's Syndrome and Salivary Gland Dysfunction Unit, NIDCR/NIH, Bethesda, MD, USA
Oral Dis, 2019 Jun;25 Suppl 1:79-87.
PMID: 31140691 DOI: 10.1111/odi.13051

Abstract

Long non-coding RNAs (lncRNA) modulate gene expression at the epigenetic, transcriptional and post-transcriptional levels and are involved in tumorigenesis. They can form complex secondary and tertiary structures and have been shown to act as precursors, enhancers, reservoirs and decoys in the complex endogenous RNA network. They were first reported in relation to oral squamous cell carcinoma (OSCC) in 2013. Here, we summarise the functional roles and pathways of the most commonly studied lncRNAs in OSCC. Existing research demonstrates the involvement of lncRNA within pivotal pathways leading to the development and spread of OSCC, including interactions with key cancer-associated microRNAs such as miR-21. The number of studies on lncRNA and OSCC remains limited in this new field. As evidence grows, the tissue-specific expression patterns of lncRNAs should further advance our understanding of the altered regulatory networks in OSCC and possibly reveal new biomarkers and therapeutic targets.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.